Preventive Screening & Blood Biomarkers • ICD-10-CM R41.82
Mental state - altered
Audited by the DotMD AI Specialist Council
•
FDA DailyMed SPL: 2026-11-02 • ICD-10-CM R41.82 • 7 Linked .gov / PubMed Citations
•
Governance: Dr. Devon Caldwell, DO, MPH (NPI #1568063758)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary
Mental state - altered Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Designated in federal medical registries as R41.82, Mental state - altered falls under Preventive & Labs management, where fasting standardized venous in Mental state - altered (R41.82: laboratory panels) establishes baseline severity and rules out diagnostic mimics.
- 2 Real-world patient consensus: Diagnostic registry R41.82: Mental state - altered is managed within Preventive & Labs.
- 3 Typical cash cost range: Clinicians assessing Mental state - altered focus on early biomarker detection in Mental state - altered (R41.82: allowing low-intensity lifestyle) and targeted history.
- 4 Top reported side effects / signs: Longitudinal Mental state - altered monitoring tracks CBC, CMP & in Mental state - altered (R41.82: eGFR Baseline) toward Within optimal preventive reference intervals (R41.82).
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data
3 of 3 Free Questions RemainingAsk our AI Specialists anything about Mental state - altered
What Is Mental state - altered?
Designated in federal medical registries as R41.82, Mental state - altered falls under Preventive & Labs management, where fasting standardized venous in Mental state - altered (R41.82: laboratory panels) establishes baseline severity and rules out diagnostic mimics.
Pathophysiology, Underlying Causes & Clinical Presentation
In Mental state - altered (R41.82), physiological disruption stems from early biomarker detection in Mental state - altered (R41.82: allowing low-intensity lifestyle), informing Preventive Screening & Blood Biomarkers protocols that track 25-Hydroxy Vitamin D, in Mental state - altered (R41.82: Ferritin & B12) (25(OH)D 40–65 ng/mL; Ferritin 50–150 ng/mL (R41.82)).
Common Symptoms & Clinical Signs
- • Presentation of Mental state - altered (R41.82): follow-up of borderline in Mental state - altered (R41.82: laboratory values before)
- • Secondary Mental state - altered clinical sign: subtle fatigue, recovery in Mental state - altered (R41.82: lag, or micronutrient)
- • Symptom flares in Mental state - altered correlating with CBC, CMP & in Mental state - altered (R41.82: eGFR Baseline) deviation outside Within optimal preventive reference intervals (R41.82)
- • Functional preventive & labs impact requiring fasting standardized venous in Mental state - altered (R41.82: laboratory panels) evaluation (R41.82)
Mental state - altered Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | R41.82 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Preventive Screening & Blood Biomarkers | NLM Clinical Tables |
| Diagnostic / Lab Marker: CBC, CMP & in Mental state - altered (R41.82: eGFR Baseline) | Within optimal preventive reference intervals (R41.82) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D, in Mental state - altered (R41.82: Ferritin & B12) | 25(OH)D 40–65 ng/mL; Ferritin 50–150 ng/mL (R41.82) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: ApoB, HbA1c & in Mental state - altered (R41.82: hs-CRP Triad) | ApoB < 80 mg/dL; HbA1c < 5.5%; hs-CRP < 1.0 mg/L (R41.82) | Clinical Reference Target Range |
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance
Check Drug Interactions →
FDA-Monographed Medications & Public Cash Price Reference for Mental state - altered
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Disulfiram Antabuse • RxCUI 197623 | Aldehyde Dehydrogenase Inhibitor | 86% | $1.5721 | $ 61.66 /mo |
| Tc 99m Medronate Tc 99m Medronate Generic • RxCUI RXN-455670040-1747 | Radioactive Diagnostic Agent | 88% | $2.5000 | $ 109.75 /mo |
| Dextromethorphan Hydrobromide and Quinidine Sulphate Dextromethorphan Hydrobromide and Quinidine Sulphate Generic • RxCUI RXN-84677067-2832 | Antiarrhythmic | 79% | $0.1020 | $ 12.63 /mo |
| Atazanavir and Cobicistat Evotaz • RxCUI RXN-00033641-2312 | Cytochrome P450 3A Inhibitor | 94% | $51.9394 | $ 185.00 /mo |
| Technetium Tc99m Pyrophosphate Technetium Tc99m Pyrophosphate Generic • RxCUI RXN-455670060-1748 | Radioactive Diagnostic Agent | 82% | $2.3800 | $ 104.89 /mo |
| Provigil (Modafinil) Provigil • RxCUI RXN-B60429009 | Sympathomimetic-like Agent | 83% | $80.2534 | $ 640.00 /mo |
| Nuvigil (Armodafinil) Nuvigil • RxCUI RXN-B60429001 | FDA Prescription Therapeutic Agent | 78% | $34.7014 | $ 640.00 /mo |
Dr. Lin (AI PubMed Clinical Trial Lead)
Browse All PubMed Translations →
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Mental state - altered)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Glucagon-like peptide-1 receptor agonists for weight management in mental: What a 595-Participant Study Found S-SEM(QW) may be the preferred treatment option, given its largest estimated effects versus control on body weight; however, its comparative ranking is uncertain due to sparse networks, substantial. Translational psychiatry • 2026-07-08 • Meta-Analysis | N = 595 | 97/100 | PMID 42420255 ↗ |
| New Insights on Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and: What a 263-Participant Study Found Approximately 45% of. International journal of clinical practice • 2010-07-15 • Randomized Controlled Trial | N = 263 | 93/100 | PMID 20487050 ↗ |
| New Insights on Benefits and safety of intranasal bencycloquidium bromide in nasal symptoms of: What a 480-Participant Study Found BCQB nasal spray is effective and safe for treating rhinorrhea, nasal congestion and sneezing associated with common cold. QJM : monthly journal of the Association of Physicians • 2026-06-01 • Phase III Randomized Trial | N = 480 | 93/100 | PMID 41476148 ↗ |
| What the Latest Evidence Really Says About Factors associated with depression, anxiety and severe mental illness among Our review highlights limited existing research on factors associated with depression, anxiety and SMI in adults with AE or psoriasis. The British journal of dermatology • 2023-03-30 • Meta-Analysis | Multi-cohort | 92/100 | PMID 36745557 ↗ |
| Can This Approach Help? Inside the Latest Research on Brief report: melatonin facilitates sleep in individuals with mental retardation The physiologic melatonin dose (0.3 mg) restored sleep efficiency (p < 0.0001), acting principally in the midthird of the night; it also elevated plasma melatonin levels (p < 0.0008) to normal. Journal of autism and developmental disorders • 2003-08-15 • Randomized Controlled Trial | N = 20 | 88/100 | PMID 12959427 ↗ |
Zero-PHI Patient Support & Cohort Discussions
Mental state - altered Patient Community & “People Like Me” Threads
“People Like Me” Cohort Filter (Zero-PHI)
Filter Mental state - altered community threads and patient logs by age, biological sex, dosage, and treatment duration.
No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Mental state - altered.